Acute transplant glomerulopathy with monocyte rich infiltrate

Transplant Immunology

Volumn 29, Issue 1-4, 2013, Pages 114-117

  Lenihan, Colin R ^a   Tan, Jane C ^a   Kambham, Neeraja ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute transplant glomerulopathy; Alemtuzumab; Kidney transplantation; Macrophage; Monocyte; Transplant glomerulitis

Indexed keywords

ALEMTUZUMAB; COTRIMOXAZOLE; DOXYCYCLINE; FIBRINOGEN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VALGANCICLOVIR;

ACUTE TRANSPLANT GLOMERULOPATHY; ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CD20+ B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL SWELLING; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; END STAGE RENAL DISEASE; ENDOTHELIUM CELL; FEMALE; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFECTION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTIC INFILTRATION; MAINTENANCE THERAPY; MICROALBUMINURIA; MIDDLE AGED; MONOCYTE; NEUTROPHIL COUNT; PRIORITY JOURNAL; RECURRENT DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE TRANSPLANT GLOMERULOPATHY; ALEMTUZUMAB; KIDNEY TRANSPLANTATION; MACROPHAGE; MONOCYTE; TRANSPLANT GLOMERULITIS;

ACUTE DISEASE; ALLOGRAFTS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LUPUS NEPHRITIS; MIDDLE AGED; MONOCYTES;

EID: 84897053386     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2013.09.004     Document Type: Article

References (34)

1. Yabu J.M., Higgins J.P., Chen G., Sequeira F., Busque S., Tyan D.B. C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 2011, 91(3):342-347.
2. Axelsen R.A., Seymour A.E., Mathew T.H., Canny A., Pascoe V. Glomerular transplant rejection: a distinctive pattern of early graft damage. Clin Nephrol 1985, 23(1):1-11.
3. Husain S., Sis B. Advances in the understanding of transplant glomerulopathy. Am J Kidney Dis 2013, 62(2):352-363. [Aug]. 10.1053/j.ajkd.2012.10.026.
4. Maryniak R.K., First M.R., Weiss M.A. Transplant glomerulopathy: evolution of morphologically distinct changes. Kidney Int 1985, 27(5):799-806.
5. Haas M., Mirocha J. Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. Am J Transplant 2011, 11(10):2123-2131.
6. Cosio F.G., Gloor J.M., Sethi S., Stegall M.D. Transplant glomerulopathy. Am J Transplant 2008, 8(3):492-496.
7. Batal I., Azzi J., El-Haddad N., Riella L.V., Lunz J.G., Zeevi A., et al. Immunohistochemical markers of tissue injury in biopsies with transplant glomerulitis. Hum Pathol 2012, 43(1):69-80.
8. Magil A.B. Infiltrating cell types in transplant glomerulitis: relationship to peritubular capillary C4d deposition. Am J Kidney Dis 2005, 45(6):1084-1089.
9. Wavamunno M.D., O'Connell P.J., Vitalone M., Fung C.L., Allen R.D., Chapman J.R., et al. Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007, 7(12):2757-2768.
10. Cosio F.G., Sedmak D.D., Henry M.L., Al Haddad C., Falkenhain M.E., Elkhammas E.A., et al. The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients. Transplantation 1996, 62(8):1054-1059.
11. Gallay B.J., Alpers C.E., Davis C.L., Schultz M.F., Johnson R.J. Glomerulonephritis in renal allografts associated with hepatitis C infection: a possible relationship with transplant glomerulopathy in two cases. Am J Kidney Dis 1995, 26(4):662-667.
12. Haas M. Transplant glomerulopathy: it's not always about chronic rejection. Kidney Int 2011, 80(8):801-803.
13. Baid-Agrawal S., Farris A.B., Pascual M., Mauiyyedi S., Farrell M.L., Tolkoff-Rubin N., et al. Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int 2011, 80(8):879-885.
14. Sis B., Campbell P.M., Mueller T., Hunter C., Cockfield S.M., Cruz J., et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007, 7(7):1743-1752.
15. Akalin E., Dinavahi R., Dikman S., de Boccardo G., Friedlander R., Schroppel B., et al. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol 2007, 2(6):1261-1267.
16. Sis B., Mengel M., Haas M., Colvin R.B., Halloran P.F., Racusen L.C., et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010, 10(3):464-471.
17. Olsen S., Spencer E., Cockfield S., Marcussen N., Solez K. Endocapillary glomerulitis in the renal allograft. Transplantation 1995, 59(10):1421-1425.
18. Messias N.C., Eustace J.A., Zachary A.A., Tucker P.C., Charney D., Racusen L.C. Cohort study of the prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts. Transplantation 2001, 72(4):655-660.
19. Batal I., Lunz J.G., Aggarwal N., Zeevi A., Sasatomi E., Basu A., et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant 2010, 10(11):2442-2452.
20. Sis B., Jhangri G.S., Riopel J., Chang J., de Freitas D.G., Hidalgo L., et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2012, 12(5):1168-1179.
21. Papadimitriou J.C., Drachenberg C.B., Munivenkatappa R., Ramos E., Nogueira J., Sailey C., et al. Glomerular inflammation in renal allografts biopsies after the first year: cell types and relationship with antibody-mediated rejection and graft outcome. Transplantation 2010, 90(12):1478-1485.
22. Fahim T., Böhmig G.A., Exner M., Huttary N., Kerschner H., Kandutsch S., et al. The cellular lesion of humoral rejection: predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant 2007, 7(2):385-393.
23. Sis B., Halloran P.F. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010, 15(1):42-48.
24. Loupy A., Suberbielle-Boissel C., Hill G.S., Lefaucheur C., Anglicheau D., Zuber J., et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009, 9(11):2561-2570.
25. Kieran N., Wang X., Perkins J., Davis C., Kendrick E., Bakthavatsalam R., et al. Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure. J Am Soc Nephrol 2009, 20(10):2260-2268.
26. Magil A.B., Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003, 63(5):1888-1893.
27. Tinckam K.J., Djurdjev O., Magil A.B. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005, 68(4):1866-1874.
28. Meehan S.M., Chang A., Khurana A., Baliga R., Kadambi P.V., Javaid B. Pauci-immune and immune glomerular lesions in kidney transplants for systemic lupus erythematosus. Clin J Am Soc Nephrol 2008, 3(5):1469-1478.
29. Hanaway M.J., Woodle E.S., Mulgaonkar S., Peddi V.R., Kaufman D.B., First M.R., et al. Alemtuzumab induction in renal transplantation. N Engl J Med 2011, 364(20):1909-1919.
30. Hill P., Gagliardini E., Ruggenenti P., Remuzzi G. Severe early acute humoral rejection resulting in allograft loss in a renal transplant recipient with Campath-1H induction therapy. Nephrol Dial Transplant 2005, 20(8):1741-1744.
31. Kirk A.D., Hale D.A., Mannon R.B., Kleiner D.E., Hoffmann S.C., Kampen R.L., et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003, 76(1):120-129.
32. Gallon L., Gagliardini E., Benigni A., Kaufman D., Waheed A., Noris M., et al. Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H). Clin J Am Soc Nephrol 2006, 1(3):539-545.
33. Zafrani L., Truffaut L., Kreis H., Etienne D., Rafat C., Lechaton S., et al. Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. Am J Transplant 2009, 9(8):1816-1825.
34. Hurst F.P., Belur P., Nee R., Agodoa L.Y., Patel P., Abbott K.C., et al. Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States Renal Data System. Transplantation 2011, 92(1):36-40.